ArticleCancers2020

Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Adrien Costantini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.